期刊文献+

非小细胞肺癌术后三维适形放疗与常规放疗结果比较 被引量:3

Comparison of postoperative three-dimensional conformal radiotherapy with conventional radiotherapy for non-small cell lung cancer
原文传递
导出
摘要 目的回顾性比较非小细胞肺癌术后三维适形放疗(3DCRT)和常规放疗的疗效、失败模式及副反应。方法分析3年余接受术后放疗的ⅠB~ⅢB期非小细胞肺癌患者162例,其中86例采用3DCRT,76例采用常规放疗。结果总随访率91.5%,3DCRT和常规放疗的中位随访时间分别为29.4个月和33.8个月。3DCRT和常规放疗的1、2、3年无局部进展生存率分别为97.5%、83.2%、83.2%和84.3%、76.0%、65.6%(χ^2=5.46,P=0.019),总生存率、无疾病进展生存率和无远转生存率均相似;总局部区域失败率分别为14.5%和33.3%(χ^2=7.70 P=0.006),远处转移率两组相似。2—3级放射性肺炎发生率3DCRT显著低于常规放疗(11.6%:23.7% χ^2=4.10,P=0.043)。结论术后放疗采用3DCRT技术比常规放疗技术能提高局部控制率,降低放疗相关副反应发生率。 Objective To compare postoperative three-dimensional conformal radiotherapy (3DCRT) and conventional radiotherapy (CR) in patients with non-small-cell lung cancer (NSCLC). Methods From Nov. 2002 to Mar. 2006,162 patients with stage Ⅰ B-Ⅲ B NSCLC receiving postoperative radiotherapy in our department were restrospetcively analyzed. Among them ,86 received 3DCRT and 76 received CR. The survival outcome, pattern of failure and treatment-related side effects in both groups were analyzed. Results The median follow-up was 29.4 months in the 3DCRT group and 24 months in the CR group. The 1-,2- and 3-year local-regional free survival was 97.5% ,83.2% and 83.2% in 3DCRT group, and 84.3% ,76.0% and 65.6% in CR group( χ^2 = 5.46, P = 0. 019), respectively. No statistically significant difference was found in the overall survival, disease-free survival or distant metastasis-free survival between the two groups. The local-regional failure rate was statistically different between the two groups (14.5% vs 33.3% ,X2 =7.70,P =0. 006). The incidence of distant metastasis in the two groups was similar. Radiation pneumonitis of NCI CTC grade 2-3 occurred in 10 patients( 11.6% )in 3DCRT group and 18 (23.7%) in CR group, which was statistically different ( χ^2 = 4.10, P = 0. 043 ). Conclusions Postoperative 3DCRT for NSCLC provides a better local-regional control and lower incidence of radiation pneumonitis compared with CR.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2009年第2期96-100,共5页 Chinese Journal of Radiation Oncology
关键词 肺肿瘤/放射疗法 三维适形 常规分割 预后 Lung neoplasms/radiotherapy Three-dimensional conformal Conventional fraetionational Prognosis
  • 相关文献

参考文献18

  • 1The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage Ⅱ and stage Ⅲ epidermoid cancer of the lung. N Engl J Med,1986,315:1377-1381.
  • 2Stephens R, Girling D J, Bleehen NM. The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical research council lung cancer working party. Br J Cancer, 1996,74:632-639.
  • 3Dautzenberg B, Arriagada R, Chammard AB, et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Cancer, 1999,86:265-273.
  • 4Douillard JY, Rosell R, Lena MD, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage Ⅰ B - Ⅲ A non smaU cell lung cancer ( adjuvant navelbine international trialist association [ ANITA ] ) : a randomised controlled trial. Lancet 0ncol,2006,7:719-727.
  • 5PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet Oncol, 1998,352:257-263.
  • 6Machtay M, Lee JH, Shrager JB, et al. Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small-cell lung carcinoma. J Clin Oncol,2001,19 :3912-3917.
  • 7Unoa T, Sumib M, Kiharac A, et al. Postoperative radiotherapy for non-small-cell lung cancer: results of the 1999-2001 patterns of care study nationwide process survey in Japan. Lung Cancer, 2007,56:357-362.
  • 8Bekelman JE. Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2006,66:492-499.
  • 9Bonner J. The role of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma: seeking to optimize local control and survival while minimizing toxicity. Cancer, 1999,86 : 195-196.
  • 10Lally BE, Zeherman D, Colasanto JM, et al. Postoperative radiotherapy for stage Ⅱ or Ⅲ non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol, 2006,24 : 2998 -3006.

二级参考文献2

共引文献29

同被引文献9

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部